Vinylbital

Vinylbital, also known as butylvinal, is a sedative hypnotic drug which is a barbiturate derivative.[1] It was developed by Aktieboleget Pharmacia in the 1950s.[2]

Vinylbital
Clinical data
Routes of
administration		Oral
ATC code
Legal status
Legal status
  • CA: Schedule IV
  • DE: Anlage II (Authorized trade only, not prescriptible)
  • US: Schedule IV
Pharmacokinetic data
MetabolismHepatic
ExcretionRenal
Identifiers
IUPAC name
  • 5-(1-methylbutyl)-5-vinylpyrimidine-2,4,6(1H,3H,5H)-trione
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ECHA InfoCard100.017.633
Chemical and physical data
FormulaC11H16N2O3
Molar mass224.260 g·mol−1
3D model (JSmol)
SMILES
  • O=C1NC(=O)NC(=O)C1(\C=C)C(C)CCC
InChI
  • InChI=1S/C11H16N2O3/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h5,7H,2,4,6H2,1,3H3,(H2,12,13,14,15,16) Y
  • Key:KGKJZEKQJQQOTD-UHFFFAOYSA-N Y
 NY (what is this?)  (verify)

References
  1. Breimer DD, de Boer AG (1976). "Pharmacokinetics and relative bioavailability of vinylbital in man after oral and rectal administration". Arzneimittel-Forschung. 26 (3): 448–54. PMID 989344.
  2. US 2868790, Brandstrom AE, "Manufacture of Barbituric Acid Compounds", issued 13 January 1959, assigned to Pharmacia
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.